BioGeometry Announces Strategic Cooperation with Symary Biopharma for the Large Molecule Drug R&D

Both parties will fully leverage their respective strengths in a comprehensive strategic collaboration within the field of large molecule pharmaceuticals, aiming to achieve breakthrough progress in antibody drug R&D through the application of AI technology.

Learn MoreBioGeometry Announces Strategic Cooperation with Symary Biopharma for the Large Molecule Drug R&D